Business Context and Reporting Period
Envista Holdings Corporation filed this Form 8-K on June 30, 2023, under Item 5.02. The filing concerns the departure of Jean-Claude Kyrillos, Senior Vice President and President of Diagnostics and Digital Solutions. It is not a quarterly earnings or financial-results filing.
Financial and Liquidity Information
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics. It discloses expected separation-related payments totaling approximately $1.096 million, consisting of:
- $892,500 in severance, payable in installments over 12 months.
- $183,750 representing a pro rata 2023 annual incentive payment, calculated using 100% Company and 100% Personal Performance Factors.
- $19,313 as a lump-sum payment for 12 months of group health, prescription, vision, and dental coverage premiums.
Material Changes Versus the Prior Comparable Period
Mr. Kyrillos’s employment termination became effective June 30, 2023, pursuant to a previously reported mutual agreement. The Company entered into a Separation Agreement and General Release providing for the payments described above and a release of claims in favor of the Company.
Outlook, Risks, Contingencies, and Unusual Items
- The Separation Agreement will not become effective and enforceable until expiration of the seven-day revocation period.
- Mr. Kyrillos is required to continue complying with confidentiality, non-disparagement, non-solicitation, and non-competition obligations, among other requirements.
- The filing states that the complete Separation Agreement will be filed with the Company’s Form 10-Q for the quarter ended June 30, 2023.
- The disclosed payments represent an unusual separation-related obligation; the filing does not specify the accounting period or financial statement treatment.
Important Facts for Investors to Verify
- Confirm that the Separation Agreement became effective after the seven-day revocation period.
- Review the complete agreement when filed with the June 30, 2023 Form 10-Q.
- Verify the timing and accounting treatment of the approximately $1.096 million in separation-related payments.
- Assess any resulting leadership or operating impact within the Diagnostics and Digital Solutions business.